Molecular Diagnosis & Therapy (Record no. 3553)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02001nas a22003495i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1179-2000 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260610082520.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 150723s||||||||sz uu poo|||||| b|EN |d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1179-2000 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/40291.1179-2000 |
| Source of number or code | doi |
| 210 10 - ABBREVIATED TITLE | |
| Abbreviated title | Mol Diagn Ther |
| 245 10 - TITLE STATEMENT | |
| Title | Molecular Diagnosis & Therapy |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Alison Fitches. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing : |
| -- | Imprint: Adis. |
| 300 ## - online resource | |
| Other physical details | online resource. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Molecular Diagnosis & Therapy welcomes current opinion articles on emerging or contentious issues, comprehensive narrative reviews, systematic reviews (as outlined by the PRISMA statement), original research articles (including short communications) and letters to the editor. All manuscripts are subject to peer review by international experts. Topic coverage of the journal includes: Use of biomarkers to guide drug development and to serve as diagnostics or prognostic tools. Detection, monitoring, and treatment of molecular causes of disease. Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects, and/or disease progression. Drug/diagnostic combinations (theranostics). Emerging molecular diagnostic tools and technologies. Pathogen detection and drug resistance analysis. Ethical and regulatory issues relating to precision medicine. . |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine—Research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biology—Research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medical genetics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Therapeutics. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomedical Research. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medical Genetics. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer Biology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Therapeutics. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fitches, Alison. |
| Relator term | editor. |
| Relationship | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed version: |
| International Standard Serial Number | 1177-1062 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/40291.1179-2000">https://doi.org/10.1007/40291.1179-2000</a> |
| Public note | Hybrid |
No items available.